-
@ Layer3.news
2025-05-19 13:33:08
nostr:nprofile1qy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqgr8g2hyzql5lt4cxfjdj40hgtu6vydvsqvsesqy8canygcce3lwvyyapkyy
REGENERON PHARMACEUTICALS TO ACQUIRE 23ANDME FOR $256M
https://s.yimg.com/ny/api/res/1.2/jMekiCT4mZ2_S7szsjNT5A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3
--
✍️ Regeneron Pharmaceuticals acquires 23andMe for $256 million, acquiring its Personal Genome Service, Total Health, and Research Services business line, and Biobank and associated assets.
--
👉 Regeneron acquires 23andMe for $256 million
👉 Deal includes Personal Genome Service, Total Health, and Research Services business line, and Biobank and associated assets
👉 Deal subject to bankruptcy court and regulatory approvals
👉 Expected to close by third quarter of 2025
--
#GeorgeD.Yancopoulos #business
--
nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqg9s2xnxyfuus84l4kutj7tkzhe2l20p4xsrrgualqaxxre28c72hsmkelup